Wolfe Research Downgrades Inspire Medical Systems (INSP) to Peerperform

Wolfe Research analyst Mike Polark downgraded Inspire Medical Systems (NYSE: INSP) from Outperform to Peerperform.

The analyst commented: "This was a swing from us & complete miss. Feel dumb & slightly angry (at ourselves/CMS). Sigh. It’s cheap but believing with conviction the lowered guide is difficult given reduced doctor incentive. And ahead things get trickier. I.e., GLP-1s, NYXH, LIVN, Apnimed."

For an analyst ratings summary and ratings history on Inspire Medical Systems click here. For more ratings news on Inspire Medical Systems click here.

Shares of Inspire Medical Systems closed at $59.65 yesterday.

You May Also Be Interested In

• Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
• BAE Systems Plc (BA:LN) (BAESY) New Top Pick in EU Defence at Morgan Stanley
• BofA Securities Starts LTM Ltd (LTM:IN) at Underperform